// App-Quantinova.ai

4668 : Allogeneic Hematopoietic Stem Cell Transplantation for Primary Refractory Acute Lymphoblastic Leukemia - a Report from the Acute Leukemia Working Party of the EBMT

Researchers

Presenter

  • Myriam Labopin

Principal Investigators

  • Johanna Tischer

  • Ioanna Sakellari

  • Sebastian Giebel

  • Matthias Stelljes

  • Jurgen Finke

  • Renato Fanin

  • Gernot Stuhler

  • Boris V Afanasyev

  • Adrian Bloor

  • Achilles Anagnostopoulos

  • Mohamad Mohty

Medical Centers

  • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine,University of Tel-Aviv, Tel-Aviv, Israel

  • EBMT Paris study office / CEREST-TC, Saint Antoine Hospital, Paris, France,

  • Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany

  • Zentrum fur Blutstammzell- und Knochenmarktransplantation, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany

  • Department of Haematology, Imperial College London, Hammersmith Hospital, London, United Kingdom

  • Universitatsklinikum Munster, Munster, Germany

  • Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany

  • R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, Academician I.P.Pavlov First St.Petersburg State Medical University, Saint-Petersburg, Russia

  • Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland,

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy

Locations

  • Greece

  • Italy

  • Poland

  • Germany

  • United Kingdom

  • Israel

  • France

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved